导致造影剂肾病的易患因素分析(2)
 |
| 第1页 |
参见附件(1322KB，2页)。
[参考文献]
[1]Berg KJ.Nephrotoxicity related to contrast media[J].Scand J Urol Nephrol,2000,34(5):317-322.
[2]Cigarroa RG,Lenge RA,Wililams RH,et al.Dosing of contrast material to prevent nephropathy in patients with renal disease[J].AmJ Med,1989, 86:649-652.
[3]Marenzi G,Lauri G,Assanelli E,et al.Contrast-induced nephropathy in p- atients undergoing primary angioplasty for acute myocardial infarction[J].J Am Coll Cardiol,2004,44:1780-1785.
[4]Rihal CS,Textor SC,Grill DE,et al.Incidence and prognostic importance of Acute renal failure after pereutaneous coronary intervention[J].Circulation,2002,105:2259-2264.
[5]Marcos SK, Thomsen HS, Webb JA. Contrast-media-induced nepheotoxicity:a consensus report. Contrast Media Safety Committee,European Society of Urogenital Radiology(ESUR)[J].Eur Radial,1999,(9):1602-1613.
[6]Epstein M.Aging and the kidney[J].J Am Soc Nephrol,1996,7(8):1106-1122.
[7]Duncan L,Heathcote J,Djurdje O,et a1.Screening for renal disease using serum creatinine：who are we missing[J].Nephrol Dial Transplant,2001,16(5):1042-1046.
[8]钱越洲,朱利民,刘宇,等.黄芪注射液预防冠状动脉介入后造影剂肾病的研究[J].中国现代医生,2008,46(13):33-34.
(收稿日期：2009-02-26)
您现在查看是摘要介绍页，详见PDF附件(1322KB，2页)。